Emcure Pharmaceuticals IPO subscribed 5.01 times in two days: Bansal Wire Industries issue also subscribed 6.06 times, today is the last day of bidding

Today is the last day of bidding for the Initial Public Offer (IPO) of Emcure Pharmaceuticals Limited and Bansal Wire Industries Limited. Emcure Pharmaceuticals Limited’s IPO was subscribed a total of 5.01 times in two days. This issue was subscribed 3.55 times in the retail category, 0.97 times in qualified institutional buyers (QIB) and 13.99 times in the non-institutional investors (NII) category. At the same time, Bansal Wire Industries Limited’s IPO was subscribed a total of 6.06 times in two days. This issue was subscribed 6.57 times in the retail category, 0.10 times in QIB and 12.84 times in the NII category. Shares of both the companies will be listed on the National Stock Exchange (NSE) and Bombay Stock Exchange (BSE) on July 10. Let us now know about the IPO of these two companies one by one :- 1. Emcure Pharmaceuticals Limited Emcure Pharmaceuticals Limited wants to raise a total of ₹ 1,952.03 crore through this IPO. For this, the company is issuing 7,936,507 fresh shares worth ₹ 800 crore. Whereas, the existing investors of the company are selling 11,428,839 shares worth ₹ 1,152.03 crore through Offer for Sale i.e. OFS. Retail investors can bid for a maximum of 196 shares Emcure Pharmaceuticals Limited has fixed the price band of this issue as ₹ 960-₹ 1008. Retail investors can bid for a minimum of one lot i.e. 14 shares. If you apply for 1 lot as per the upper price band of ₹1008 of the IPO, then you will have to invest ₹14,112 for it. At the same time, retail investors can apply for a maximum of 13 lots i.e. 196 shares. For this, investors will have to invest ₹197,568 as per the upper price band. Premium of Emcure Pharmaceuticals in the grey market is 33.23% Before listing, the company’s stock has reached a premium of 33.23% i.e. ₹335 per share in the grey market. In such a situation, according to the upper price band of ₹1008, its listing can happen at ₹1343. However, only an estimate can be made from this, the listing price of the share is different from the price of the grey market. Emcure Pharmaceuticals was founded in 1981 Emcure Pharmaceuticals is an Indian pharma company, founded in 1981. The company manufactures and markets medicines globally as well as conducts research. Emcure Pharmaceuticals has 13 manufacturing facilities in India. These facilities can produce a variety of pharmaceutical and biopharmaceutical products, including tablets, liquid substances and injections. 2. Bansal Wire Industries Limited Bansal Wire Industries Limited wants to raise a total of ₹ 745 crore through this IPO. For this, the company is issuing 29,101,562 shares worth a total of ₹ 745 crore. The existing investors of the company are not selling a single share through the offer for sale. Retail investors can bid for a maximum of 754 shares Bansal Wire Industries Limited has fixed the price band of this issue at ₹243-₹256. Retail investors can bid for a minimum of one lot i.e. 58 shares. If you apply for 1 lot as per the IPO’s upper price band of ₹256, then you will have to invest ₹14,848 for it. At the same time, retail investors can apply for a maximum of 13 lots i.e. 754 shares. For this, investors will have to invest ₹193,024 as per the upper price band. Premium of Bansal Wire Industries in the grey market is 23.44% Before listing, the company’s shares have reached a premium of 23.44% i.e. ₹60 per share in the grey market. In such a situation, according to the upper price band of ₹ 256, its listing can be at ₹ 316. However, this can only be estimated, the listing price of the share is different from the grey market price. Bansal Wire Industries was established in 1985 Bansal Wire Industries Limited is a stainless steel wire manufacturing company, which was established in December 1985. The company manufactures more than 3,000 types of steel wire products, ranging in size from very thin to very thick. Along with selling its products in the country, the company also exports its products to more than 50 countries. 35% of both IPOs reserved for retail investors In both IPOs, 50% of the issue has been reserved for Qualified Institutional Buyers (QIB). Apart from this, 35% is reserved for retail investors and the remaining 15% is reserved for non-institutional investors (NII). What is an IPO? When a company issues its shares to the general public for the first time, it is called Initial Public Offering or IPO. The company needs money to expand its business. In such a situation, instead of taking a loan from the market, the company raises money by selling some shares to the public or by issuing new shares. For this, the company brings IPO.

Leave a Comment

Your email address will not be published. Required fields are marked *

Scroll to Top